Armistice Capital, LLC 13D and 13G filings for Coeptis Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 3:59 pm Sale |
2024-09-30 | 13G | Coeptis Therapeutics, Inc. COEP |
Armistice Capital, LLC | 94,774 4.990% |
-81,227 (-46.15%) |
Filing |
| 2024-02-14 3:32 pm Purchase |
2023-12-31 | 13G | Coeptis Therapeutics, Inc. COEP |
Armistice Capital, LLC | 176,000 9.960% |
176,000 (New Position) |
Filing |